103 related articles for article (PubMed ID: 11856839)
1. Crystallization and preliminary X-ray diffraction studies of human angiostatin.
Abad MC; Geiger J
Acta Crystallogr D Biol Crystallogr; 2002 Mar; 58(Pt 3):513-4. PubMed ID: 11856839
[TBL] [Abstract][Full Text] [Related]
2. The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.
Abad MC; Arni RK; Grella DK; Castellino FJ; Tulinsky A; Geiger JH
J Mol Biol; 2002 May; 318(4):1009-17. PubMed ID: 12054798
[TBL] [Abstract][Full Text] [Related]
3. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
[TBL] [Abstract][Full Text] [Related]
4. Angiostatin and angiostatin-related proteins.
Soff GA
Cancer Metastasis Rev; 2000; 19(1-2):97-107. PubMed ID: 11191071
[TBL] [Abstract][Full Text] [Related]
5. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen.
Heidtmann HH; Nettelbeck DM; Mingels A; Jäger R; Welker HG; Kontermann RE
Br J Cancer; 1999 Dec; 81(8):1269-73. PubMed ID: 10604721
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
[TBL] [Abstract][Full Text] [Related]
7. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
8. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
9. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
O'Reilly MS
EXS; 1997; 79():273-94. PubMed ID: 9002223
[TBL] [Abstract][Full Text] [Related]
10. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
[TBL] [Abstract][Full Text] [Related]
11. X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound to a peptide from the group A streptococcal surface protein PAM.
Cnudde SE; Prorok M; Castellino FJ; Geiger JH
Biochemistry; 2006 Sep; 45(37):11052-60. PubMed ID: 16964966
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B16F10 melanoma cells.
Ambs S; Dennis S; Fairman J; Wright M; Papkoff J
Cancer Res; 1999 Nov; 59(22):5773-7. PubMed ID: 10582698
[TBL] [Abstract][Full Text] [Related]
13. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
[TBL] [Abstract][Full Text] [Related]
14. The role of angiostatin in the spontaneous bone and prostate cancers of pet dogs.
Pirie-Shepherd SR; Coffman KT; Resnick D; Chan R; Kisker O; Folkman J; Waters DJ
Biochem Biophys Res Commun; 2002 Apr; 292(4):886-91. PubMed ID: 11944897
[TBL] [Abstract][Full Text] [Related]
15. The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritis.
Sumariwalla PF; Cao Y; Wu HL; Feldmann M; Paleolog EM
Arthritis Res Ther; 2003; 5(1):R32-9. PubMed ID: 12716451
[TBL] [Abstract][Full Text] [Related]
16. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
[TBL] [Abstract][Full Text] [Related]
18. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3).
Lijnen HR; Ugwu F; Bini A; Collen D
Biochemistry; 1998 Apr; 37(14):4699-702. PubMed ID: 9548733
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of action of angiostatin: can you teach an old dog new tricks?
Moser TL; Stack MS; Wahl ML; Pizzo SV
Thromb Haemost; 2002 Mar; 87(3):394-401. PubMed ID: 11916069
[TBL] [Abstract][Full Text] [Related]
20. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
